Opsens Inc
TSX:OPS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.85
2.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Opsens Inc
Opsens Inc
Cost of Revenue
Opsens Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Opsens Inc
TSX:OPS
|
Cost of Revenue
-CA$20.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-16%
|
|
|
Titan Medical Inc
TSX:TMD
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Cost of Revenue
-$3.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cost of Revenue
-CA$24.5m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Cost of Revenue
-CA$469.6k
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
|
MedMira Inc
XTSX:MIR
|
Cost of Revenue
-CA$143.3k
|
CAGR 3-Years
41%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
20%
|
|
Opsens Inc
Glance View
Opsens, Inc. engages in the development, manufacture, supply, and installation of fiber optic systems for measuring pressure and temperature. The firm operates through two segments: Medical and Industrial. The Medical segment focuses on physiological measurement, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that is integrated in other medical devices. The company also includes optical sensor technology. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for industrial applications. The firm also offers an optical-based pressure guidewire (OptoWire) that is focused on improving the clinical outcome of patients with coronary artery disease.
See Also
What is Opsens Inc's Cost of Revenue?
Cost of Revenue
-20.4m
CAD
Based on the financial report for Aug 31, 2023, Opsens Inc's Cost of Revenue amounts to -20.4m CAD.
What is Opsens Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-16%
Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for Opsens Inc have been -14% over the past three years , -12% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
